rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1996-8-20
|
pubmed:abstractText |
Determine the incidence of prostate cancer in patients consulting for common miction disorders and serum prostatic specific antigen (PSA) between 4 and 10 ng/ml.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0755-4982
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
272-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8685164-Adenocarcinoma,
pubmed-meshheading:8685164-Aged,
pubmed-meshheading:8685164-Aged, 80 and over,
pubmed-meshheading:8685164-Biopsy, Needle,
pubmed-meshheading:8685164-Humans,
pubmed-meshheading:8685164-Male,
pubmed-meshheading:8685164-Middle Aged,
pubmed-meshheading:8685164-Neoplasm Staging,
pubmed-meshheading:8685164-Predictive Value of Tests,
pubmed-meshheading:8685164-Prostate-Specific Antigen,
pubmed-meshheading:8685164-Prostatectomy,
pubmed-meshheading:8685164-Prostatic Neoplasms
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml].
|
pubmed:affiliation |
Service d'Urologie, CHU Bichat, Paris.
|
pubmed:publicationType |
Journal Article,
English Abstract
|